|
Collection of Blood, Bone Marrow, Tumor or Tissue Samples Clinical Trials Information presented on Clinical Trials Search is not designed to be a substitute for certified medical advice, trips or professional assistance with a real medical doctor. We aren't docs. Always confer with your doctor about Collection of Blood, Bone Marrow, Tumor or Tissue Samples conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. Collection of Blood, Bone Marrow, Tumor or Tissue Samples Clinical research trials and Collection of Blood, Bone Marrow, Tumor or Tissue Samples health trials happen in many of cities across the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally measure the effectualness of new does drugs. The intention of the studies / projects is to figure out particular human healthcare questions. Clinical trials are a popular manner for doctors, government agencies, and private sector corporations to detect cures for all forms of circumstances, like Collection of Blood, Bone Marrow, Tumor or Tissue Samples. Collection of Blood, Bone Marrow, Tumor or Tissue Samples Clinical Trials and other clinical trials allow for volunteers to undergo medical treatment options before they are available to the general public. Most times the subjects get treatment for free of charge, and occasionally they are paid for their time. Occasionally there is a cost for a Collection of Blood, Bone Marrow, Tumor or Tissue Samples clinical trial. Subjects frequently get the best healthcare possible for their Collection of Blood, Bone Marrow, Tumor or Tissue Samples condition. Hazards are a reality, however, and could include more or frequent mD visits, health risks (possibly life-jeopardizing), and/or the treatment being ineffectual. Trials are federally regulated with exacting guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "C" Clinical Trials Conditions > Collection of Blood, Bone Marrow, Tumor or Tissue Samples  Collection of Blood, Bone Marrow, Tumor or Tissue Samples
Collection of Blood, Bone Marrow, Tumor or Tissue Samples
For Condition: Neoplasms,Precancerous Conditions
Status: Recruiting
Sponsor(s): National Cancer Institute (NCI) ,
Synopsis: This study will collect biological samples-blood, bone marrow, tumor or other tissue samples-for use in cancer-related research. The specimens will be used for various tests of drug resistance, blood vessel formation, cancer-causing proteins and immune functions. The purpose is to identify steps in the cancer development process that may serve as targets for treatment and to test various therapies for current and future cancer treatment clinical trials. Individuals 18 years of age and older with cancer or a pre-cancerous condition, such as colon polyps or cervical dysplasia, are eligible for this study, as are patients at high risk for cancer. In addition, patients who do not have cancer but require surgery, biopsy or other procedure for another medical reason may be included as normal specimen donors. Participants will have about 40 milliliters (3 tablespoons) of blood drawn upon entering the study and additional 40-ml samples drawn periodically during the course of treatment. No more than 120 ml of blood will be drawn over a 12-month period. Some patients may require a surgical procedure or biopsy (removal of tumor tissue) for medical reasons or as part of their enrollment in a research treatment study. In such cases, a portion of the specimens collected during those procedures will be used for the research studies in this protocol.
Details: Patients will be evaluated at NNMC Clinics. Blood samples may be collected at the initial visit and at follow-up visits. Tumor samples may be obtained by fine needle aspirate, by removal of pleural or peritoneal fluid, or by excisional biopsy, or other procedure. In general, biopsy tissue will be obtained as an additional sample at the time of a medically indicated procedure. In some cases, a biopsy may be performed only to obtain a research sample providing the tumor is accessible with a minimal risk to the patient. Specific risks will be described in a separate consent to be obtained at the time of the biopsy. Tumor samples and blood samples will be processed and/or stored for use in research efforts in the laboratories of the Cancer Therapeutics Branch, Experimental Transplant and Immunology Branch, or Genetics Branch, Center for Cancer Research, NCI at Navy.
Eligibility:
Study Type: Observational, Natural History
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: INCLUSION CRITERIA Patients must have a performance status of ECOG greater than or equal to 3 for admission to this protocol. Subjects must be at least 18 years old. Patients with any malignancy, high-risk, pre-malignant condition (for example, colonic polyps, cervical dysplasia, atypical ductal hyperplasia or oral leukoplakia), undergoing reduction mammoplasty or prophylactic mastectomy are eligible. Patients requiring a surgical procedure for any medical indication can be included on study. These patients would be considered normal donors (no diagnosis of cancer). Patients requiring biopsy or any procedure for any medical indication can be included on study. These patients will be considered normal donors (no diagnosis of cancer). Patients not requiring biopsy for a medical indication can be included on the study soley for the purpose of obtaining research samples, including blood, pleural fluid, or peritoneal fluid, or biopsy samples, providing the biopsy or aspiration procedure is of minimal risk, i.e., fine needle aspirate, bone marrow aspirate, or excisional biopsy.
Total Enrollment: 1000
Location and Contact Information:
National Cancer Institute (NCI) *Recruiting*
Bethesda, Maryland, 20892
United States
Recruiting Patient and Public Liaison Office 1-800-411-1222
Additional Information:
Study ID Numbers: 020258; 02-C-0258
Study Start Date: July 29, 2002
Record last reviewed: April 1, 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00043615
Other Neoplasms Studies:
1. A Safety and Effectiveness Study of Aroplatin in Patients with Advanced Solid Malignancies
2. Meaning-Centered Psychotherapy in Advanced Cancer
3. D-MPH in the treatment of fatigue and neurobehavioral function related to chemotherapy in adult cancer patients
4. Depsipeptide to Treat Thyroid and Other Advanced Cancers
5. Dose Determination of 5-Fluorouracil in Combination with Leucovorin and the Experimental Drug UCN-01 to Treat Cancer
Related Studies:
Other Neoplasms Clinical Trials
Other Maryland Clinical Trials
Other Bethesda Clinical Trials
Collection of Blood, Bone Marrow, Tumor or Tissue Samples
|
|
|
|
|
|
|
|
